Cargando…
Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
The recent introduction of direct oral anticoagulants, including rivaroxaban, dabigatran, apixaban, and edoxaban, for the acute treatment and secondary prevention of venous thromboembolism and in atrial fibrillation has been shown to provide greater clinical benefit than oral vitamin K antagonists....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768245/ https://www.ncbi.nlm.nih.gov/pubmed/29348918 http://dx.doi.org/10.1177/2050313X17753336 |